Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy

Changes in the Choroidal Thickness following Intravitreal Bevacizumab Injection in Chronic Central Serous Chorioretinopathy

We evaluated the effect of intravitreal bevacizumab injection (IVB) on choroidal thickness, and studied its association with the therapeutic response in chronic central serous chorioretinopathy (CSC). The clinical features of 78 eyes with chronic CSC treated with IVB from October 2014 to June 2020 w...

Full description

Bibliographic Details
Main Authors: Yoo-Ri Chung, Su Jeong Lee, Ji Hun Song
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Clinical Medicine
Subjects:
bevacizumab
central serous chorioretinopathy
choroidal thickness
Online Access:https://www.mdpi.com/2077-0383/11/12/3375

Similar Items

Similar Items